Kopran
BSE: 524280 | NSE: KOPRAN | ISIN: INE082A01010 | SECTOR: Biotechnology & DrugsOpen
249.45High
263.85Low
249.30Prev Close
247.00P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
12.32BVolume
20.71KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
255.70Ask
257.15
Company Description
- Biotechnology & Drugs
BSE
524280NSE
KOPRANISIN
INE082A01010
Kopran Limited is an India-based integrated pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (APIs). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include anti-infective, amoxycillin, ampicillin, cloxacillin and amoxy clauv. Its non-penicillin-based finished oral dosage forms include macrolides, anti-hypertensive, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management and gastroenterology. It provides ingredients in a wide range of pharmaceutical products, such as capsules, injectables and tablets, among others. The Company's APIs products include anti-hypertensive, macrolides, neuromodulator, urological, anti-infective/anti-acne, sterile carbapenems and sterile cephalosporins.
Company Officers
Surendra Somani
Executive Vice Chairman of the BoardBasant Soni
Chief Financial OfficerSunil Sodhani
Compliance Officer, Company Secretary